<<

Challenges with Celiac Disease and Intolerances

Matthew R. Riley, MD Northwest Pediatric Gastroenterology Portland, OR Objectives

 Differentiate celiac disease from other -related ailments.  Be aware of the cost, appropriate use and limitations of available screening tests for celiac disease.  Discuss emerging therapeutic options for celiac disease.  State how to provide family-centered support for those affected by celiac disease and other gluten intolerances. Wheat-related conditions

 Celiac Disease   Non-Celiac Gluten Sensitivity  Fructan Sensitivity

Why do I care? Why should my patients care?

 Treatment differs  Long term follow up and  Gluten elimination testing differs  Wheat elimination  Mandated follow up vs.  Gluten minimization prn  Fructan minimization  Child-specific  Medication  Final adult height  Long term prognosis  Bone density differs  School accommodations  Family risk differs  Self-identity and eventual autonomy  Screening? Celiac Disease What is celiac disease?

 Permanent, autoimmune enteropathy caused by an abnormal immune response to gluten in genetically susceptible individuals

 Previously known as celiac sprue, gluten-sensitive enteropathy

Celiac Disease What are the symptoms?

 “Classic”: young child with diarrhea, abdominal distention, failure to thrive, irritability  “Atypical”: any other symptom(s) known to be caused by celiac disease, esp. non-GI symptoms

Short stature Dental enamel hypoplasia Pubertal delay Refractory iron-deficiency anemia Osteopenia Arthritis Hepatitis Neuropathy Fatigue  Asymptomatic/Silent Celiac Disease Who gets celiac disease?

 About 1-2% of the world population  Almost all of whom are DQ2 or DQ8 positive  Increased risk (>4%)  Down, William and Turner syndromes  IgA deficiency  Type I Diabetes  Autoimmune thyroiditis  1st degree relatives of a celiac

Celiac Disease Gliadin

TTG Cytokines (IL2, IL15) Tk

P T APC AGA, EMA, B TTG IgA How is celiac disease diagnosed?

 Must show immunologic process (abnormal serology)  Multiple serologies available, few are helpful  Must show intestinal damage (enteropathy)  Requires endoscopy  Marsh grading system

Celiac Disease Celiac serologies

 Tissue IgA  Sensitivity >90%, specificity >90%  Highly reproducible  Endomysial IgA  Sensitivity >90%, specificity >98%  More user-dependent  Confirmatory test in Type I Diabetes  IgG  Less sensitive/specific  Can be used in the setting of IgA deficiency

J Pediatr Gastroenterol Nutr. 2012, 54(2) Celiac Disease Anti-gliadin antibodies

Antibody Sensitivity Specificity Accuracy Gliadin IgG 42% 90% 69%

Gliadin IgA 63% 90% 79%

Deamidated 65-98% 80-97% 84% gliadin IgG Deamidated 74-95% 86-95% 86% gliadin IgA

Most Oregon labs only offer deamidated gliadin antibodies.

Clin Gastroenterol Hepatol, 2008, 6(4) Celiac Disease J Pediatr Gastroenterol Nutr. 2012, 54(2)

Celiac serologies

 Beware the ‘celiac panel’ or ‘celiac reflex panel’  Can include a variety of unneeded serology  May reflex to unneeded HLA-typing  Positive anti-gliadin antibodies with negative TTG  May lead to unnecessary worry and specialty referrals  Not cost-effective for patient (? for lab ?)

Celiac Disease Thinking about cost

Ordered test Included components Cost IgA IgA $49 TTG IgA TTG IgA $79-85 Gliadin IgA/IgG DGP IgA, DPG IgG $71-109 EMA IgA EMA IgA $80-125 TTG IgG TTG IgG $85-123 TTG Antibody Panel TTG IgA, TTG IgG $150 Celiac Disease Profile IgA, EMA IgA, TTG IgA $272 Celiac Disease Profile II, Celiac IgA, EMA IgA, TTG IgA, TTG IgG $149-499 Silver Panel Celiac Gold Panel, Celiac Disease IgA, EMA IgA, TTG IgA, TTG IgG, DGP IgA, DGP IgG $179-189 Comprehensive HLA DQ 2/8 HLA DQ 2/8 $284-761 Celiac histopathology: Marsh

Normal 0 Infiltrative 1 Hyperplastic 2

Partial atrophy 3a Subtotal atrophy 3b Total atrophy 3c Celiac Disease Diagnostic Pitfalls

 Pre-treatment with gluten-free diet  Within a few weeks, mucosa can start to heal  Could improve histology to Grade 1 or 2  Well-treated celiac disease looks like no celiac disease  +TTG IgA + Marsh 0-1 OR –TTG IgA + Marsh 1  Evolving celiac disease?  Simple false-positive screening?  Non-specific finding?

Celiac Disease Celiac disease and HLA-typing

 HLA alleles associated with Celiac Disease  DQ2 found in 95% of celiac patients  DQ8 found in remaining patients  DQ2 found in ~30% of general population  DQ8 found in ~10% of general population  Value of HLA testing  High negative predictive value – Negativity for DQ2/DQ8 excludes diagnosis of Celiac Disease with 99% confidence

Celiac Disease Celiac disease and HLA-typing

General population

DQ2 or DQ8 positive

Celiac disease

Celiac Disease Celiac disease and HLA-typing

 Having DQ2 or DQ8 does not mean you have disease  Having DQ2 or DQ8 means that you are part of the 40% of the world that may one day develop celiac (and a host of other diseases)  Can lead to unnecessary testing or worry  May decrease need for regular blood testing for at- risk populations (e.g. Type I diabetes)  Often not covered by insurance: genetic testing

Celiac Disease

Other tests  Stool testing Just  Food-specific IgG tests say  Trial of gluten-free diet “No!”

Celiac Disease Associations

 Trisomy 21 (Downs syndrome)  Autoimmune thyroiditis (Hashimoto’s thyroiditis)  Dermatitis herpetaformis   Type I diabetes mellitus

Celiac Disease Wheat Allergy IgE-Mediated Wheat Allergy

 Immune-mediated reaction to food  Food allergies are most common in first year of life  Wheat is among top 10 most common food allergens  Allergy to albumin, globulin, gliadin or gluten in wheat

Wheat Allergy Symptoms of Wheat Allergy

 Abdominal pain, nausea, vomiting, rash, rhinitis, conjunctivitis, oral allergy syndrome  Must be reproducible  General poor reliability between parents’ report of suspected allergen and objective findings

Wheat Allergy Diagnosis of Wheat Allergy

 Wheat-specific IgE  Sensitivity: 20% / Specificity: 93%  Skin prick testing  Sensitivity 23% / Specificity: 100%  Patch testing  Sensitivity 86% / Specificity 35%  Double blind food elimination and challenge  GOLD STANDARD

Wheat Allergy Associations

 Can also be allergic to grain with similar proteins:  Barley, ,  Baker’s asthma  Asthma-like reaction of inhalation of uncooked wheat flours  Can usually tolerate ingestion of cooked wheat  Wheat-dependent exercise-induced anaphylaxis  Anaphylaxis with exercise or aspirin ingestion within a few hours of eating wheat

Wheat Allergy Non-Celiac Gluten Sensitivity What is non-celiac gluten sensitivity?

 Syndrome of gluten reactions in which both allergy and autoimmune mechanisms have been ruled out (not allergy, not celiac)  Negative wheat-specific IgE  Negative TTG IgA and/or EMA IgA  Normal duodenal histopathology (if done)  +/- positive anti-gliadin antibodies  +/- positive HLA DQ2/8

Non-Celiac Gluten Sensitivity What are the symptoms?

 Abdominal pain  Eczema/rash  Headache  Mild cognitive impairment / ‘foggy head’ / focus problems  Fatigue  Headache Frequently vague, somatic  Diarrhea symptoms that cannot be clinically  Depression distinguished from celiac disease  Numbness on a purely clinical basis  Joint pain

Non-Celiac Gluten Sensitivity How is it diagnosed?

 Diagnosis of exclusion  Negative TTG IgA and/or EMA IgA  Negative wheat-specific IgE  Improvement with gluten-free diet

Non-Celiac Gluten Sensitivity Fructan Sensitivity What are fructans?

 One of family of fermentable carbohydrates  FODMAP: Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols  Oligos: fructans, galactans  Disaccs: lactose  Monos: fructose  Polyols: sorbitol, mannitol, xylitol, isomalt

Fructan Sensitivity What are fructans?

 Chains of fructose molecules  Those with short chains are fructooligosaccharides  Those with long chains are called inulins  Both are soluble fibers

Fructan Sensitivity Where are fructans?

They occur in many plants  Energy storage  Confer tolerance to freezing Used as dietary fiber supplements  Beans, Onions, Garlic, Peas, Artichokes, Asparagus, Leeks, Wheat, Rye

Fructan Sensitivity What happens to fructans?

 Fructans are frequently incompletely digested in the small intestine  Residual fructans are delivered to the colon and fermented by colonic bacteria  Can result in excessive flatulence, bloating, constipation, diarrhea, nausea, abdominal pain  Sensitivity can vary widely!

Fructan Sensitivity Diagnosis of Fructan Sensitivity

 Usually empiric  Rule out celiac disease and wheat allergy  ?Fructose breath test

Fructose Breath Test 30

20 Hydrogen 10 Methane

Parts per millionper Parts 0 0 30 60 90 120 150 180 Minutes after ingestion Fructan Sensitivity Associations

 Frequently part of irritable bowel syndrome  Frequent sensitivities to other FODMAPs, especially in combination  Other functional GI disorders  Functional dyspepsia  Other chronic pain syndromes  Insomnia  Migraines

Fructan Sensitivity Treatment What to avoid Levels of tolerance Length of therapy Treatment of Celiac Disease

 <20ppm gluten  Wheat (gliadin), rye (secalin), barley (hordein)  Lifelong  Wheat-free foods are NOT necessarily gluten-free

Celiac Disease Gluten and the FDA

 2004: Food Allergen Labeling and Consumer Protection Act of directed HHS to define and permit the use of the term "gluten- free" in the labeling of foods  Final rule defines "gluten-free" as meaning:  The food either is inherently gluten free (e.g. rice)  Or does not contain an ingredient that is:  1) a gluten-containing grain (e.g. wheat);  2) derived from a gluten-containing grain that has not been processed to remove gluten (e.g. ); or  3) derived from a gluten-containing grain that has been processed to remove gluten (e.g. wheat starch),  if the use of that ingredient results in the presence of 20 parts per million (ppm) or more gluten in the food.  Also, any unavoidable presence of gluten in the food must be less than 20 ppm.

Celiac Disease http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/Allergens/ucm362510.htm Gluten and the FDA

 Does this apply to restaurants? YES  What about ? Must contain <20 ppm to be labeled gluten-free.  What about cross-contact? Must contain <20 ppm to be labeled gluten-free.  No specific testing mandated.  Compliance by summer/fall 2014  Does not apply to drugs

Celiac Disease Future Directions of Treatment of Celiac Disease Gliadin

TTG Cytokines (IL2, IL15) Tk

P T APC AGA, EMA, B TTG IgA Future Directions of Treatment of Celiac Disease

 Genetically modified gluten: decreases gluten exposure by transamidation of gluten  Zonulin inhibitor: larozotide acetate-decreases zonulin secretion and inhibits , going into Phase III trials; preliminary data in celiac patients shows fewer symptoms after intentional gluten ingestion

Celiac Disease Future Directions of Treatment of Celiac Disease

 Tissue transglutaminase inhibitors: stop TTGs from modifying gluten fragments, avoiding triggering an immune response  Therapeutic vaccine: Nexvax2: creates immune tolerance to gluten fragments and desensitizes celiac patients to their T-cell response to gluten; going into Phase IIa trial  Probiotics: Lactobacillus fermentum, Bifibobacterium lactis-detoxify gliadin and promote intestinal healing

Celiac Disease Treatment of Non-Celiac Gluten Sensitivity

 Avoid/minimize gluten  ? Amount  ? Duration  No known additional side effects if diet is not strict

Non-Celiac Gluten Sensitivity Treatment of Wheat Allergy

 Wheat elimination  Gluten-free foods are wheat-free  Anti-histamines  Epinephrine  Medical identification bracelet for anaphylaxis

Wheat Allergy Treatment of Fructan Sensitivity

 Avoidance of high-fructan foods  Artichokes, asparagus, Brussel sprouts, broccoli, cabbage, fennel, garlic, leeks, okra, onions, peas, shallots  Wheat, rye  Chickpeas, lentils, kidney beans  Watermelon, peaches, persimmon  Small amounts may be OK  Beware combination of foods with other FODMAPs

Fructan Sensitivity Health Maintenance for Celiac Disease

 NASPGHAN guidelines (2005)  “periodic assessment by physician and nutritionist”  Repeat TTG IgA by 6 months  Yearly f/u if asymptomatic  American Dietetic Association (2009)  Strong recommendation for RD consultation  Check vitamin and mineral levels (folate, ferritin, thiamin, Vitamin B12, B6, D, zinc, copper, lipid profile, electrolytes)  Supplement calcium and Vitamin D in those with reduced bone density or low 25-OH Vitamin D level  Daily multivitamin if diet intake shows nutritional inadequacies

Journal of Pediatric Gastroenterology and Nutrition, 40:1-19, Jan 2005 Celiac Disease American Dietetic Association, 2009 Health Maintenance for Celiac Disease

 American College of Gastroenterology (2013)  Referral to RD  Test iron, folic acid, vitamin D, Vitamin B12 (low level of evidence)  Periodic medical follow-up, including verification of normalization of lab abnormalities  American Gastroenterologic Association (2004)  Follow-up at regular intervals, with periodic visits with physician and dietician

American Journal of Gastroenterology 2013: 108:656-676 Celiac Disease Health Maintenance for Celiac Disease

 How are we doing? Not great…  Study of 122 patients in Olmstead County, MN with biopsy-proven celiac disease

by 1 year after Dx By 5 years after Dx Had f/u visit 41% 88.7% Assessed for compliance 33.6% 79.8% Met with RD 3.3% 15.8% Repeat serology 22.1% 65.6%

Clin Gastroenterol Hepatol 2012;10:893-899 Celiac Disease Celiac and Hepatitis B Immunity

 Park et al.—2007  26 children with celiac disease + control group, all previously immunized  53.9% of celiacs were HBsAb negative vs. 11% of controls  Ertem et al—2010  63 celiac patients on strict GFD + control group  32.5% of celiacs were HBsAb negative vs. 14.8% of controls  96.4% of HBsAb negative celiacs seroconverted after prospective immunization

J Pediatr Gastroenterol Nutr. 2007 Apr;44(4):431-5. Celiac Disease Eur J Gastroenterol Hepatol. 2010 Jul;22(7):787-93

Health Maintenance for Celiac Disease

 My practice  Referral to knowledgeable RD at time of diagnosis  Repeat serology Q3-4 months until normal or stable low value, then Q12 months  Follow up in 3 months, 6 months, yearly  Monitor growth, adherence, developmentally- appropriate guidance  Baseline CBC, CMP, Vitamin D, HBsAb  Daily gluten-free multivitamin  TTG IgA for parents, siblings >2 years of age

Celiac Disease

Take Aways

 Not everything wheat/gluten-related is celiac disease.  If you’re thinking celiac, check TTG IgA + IgA.  Non-celiac gluten sensitivity is real, but difficult to diagnosis.  Don’t forget about irritable bowel syndrome and FODMAPs.  Celiac disease is a chronic inflammatory disease and needs regular follow up and monitoring. Additional Resources

 North American Society for Pediatric Gastroenterology, Hepatology and Nutrition: www.gikids.org  Celiac Disease Foundation: www.celiac.org  American Academy of Allergy, Asthma & Immunology: www.aaaai.org/conditions-and-treatments/allergies/food-allergies.aspx  American College of Gastronterology Patient Education Center: www.patients.gi.org  International Foundation for Functional Gastrointestinal Disorders: www.iffgd.org  Monash University low FODMAP diet: www.med.monash.edu/cecs/gastro/fodmap/diet.html  U.S. Food and Drug Administration  http://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryI nformation/Allergens/default.htm